![logo](/logos/SENS.webp)
Senseonics Holdings, Inc.
AMEX:SENS
0.6 (USD) • At close November 27, 2023
Overzicht | Financiële gegevens
Bedrijfsnaam | Senseonics Holdings, Inc. |
Symbool | SENS |
Munteenheid | USD |
Prijs | 0.588 |
Beurswaarde | 310,567,488 |
Dividendpercentage | 0% |
52-weken bereik | 0.461 - 1.27 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Dr. Timothy T. Goodnow Ph.D. |
Website | https://www.senseonics.com |
An error occurred while fetching data.
Over Senseonics Holdings, Inc.
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)